First Horizon Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

First Horizon Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-262	Closed	-$20K	–	2393
2021 Q3	$20K	Hold	262	–	–	﹤0.01%	1284
2021 Q2	$21K	Hold	262	–	–	﹤0.01%	1099
2021 Q1	$20K	Buy	+262	New	+$20.4K	﹤0.01%	1076

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

First Horizon Advisors's PJP Position: Q4 2021 in Review

First Horizon Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2021, closing a stake of 262 shares — an estimated $20K sold.

First Horizon Advisors first reported a position in PJP in Q1 2021 and held it in 3 quarters. The position peaked at $21K in Q2 2021. 82 funds tracked by Wall St. Rank hold PJP as of Q4 2021.

First Horizon Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
First Horizon Advisors sold 262 Invesco Pharmaceuticals ETF shares in Q4 2021, an estimated $20K.
First Horizon Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and held it in 3 quarters.
First Horizon Advisors's Invesco Pharmaceuticals ETF position peaked at $21K in Q2 2021.
82 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2021.

Based on First Horizon Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.